Related Experiment Video
Updated: Apr 28, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Activity and architecture of pyroglutamate-modified amyloid-β (AβpE3-42) pores
Alan L Gillman1, Hyunbum Jang, Joon Lee
1Department of Bioengineering, University of California, San Diego , 9500 Gilman Drive, La Jolla, California 92093, United States.
Abstract:
Among the family of Aβ peptides, pyroglutamate-modified Aβ (AβpE) peptides are particularly associated with cytotoxicity in Alzheimer's disease (AD). They represent the dominant fraction of Aβ oligomers in the brains of AD patients, but their accumulation in the brains of elderly individuals with normal cognition is significantly lower. Accumulation of AβpE plaques precedes the formation of plaques of full-length Aβ (Aβ1-40/42). Most of these properties appear to be associated with the higher hydrophobicity of AβpE as well as an increased resistance to enzymatic degradation. However, the important question of whether AβpE peptides induce pore activity in lipid membranes and their potential toxicity compared with other Aβ pores is still open. Here we examine the activity of AβpE pores in anionic membranes using planar bilayer electrical recording and provide their structures using molecular dynamics simulations. We find that AβpE pores spontaneously induce ionic current across the membrane and have some similar properties to the other previously studied pores of the Aβ family. However, there are also some significant differences. The onset of AβpE3-42 pore activity is generally delayed compared with Aβ1-42 pores. However, once formed, AβpE3-42 pores produce increased ion permeability of the membrane, as indicated by a greater occurrence of higher conductance electrical events. Structurally, the lactam ring of AβpE peptides induces a change in the conformation of the N-terminal strands of the AβpE3-42 pores. While the N-termini of wild-type Aβ1-42 peptides normally reside in the bulk water region, the N-termini of AβpE3-42 peptides tend to reside in the hydrophobic lipid core. These studies provide a first step to an understanding of the enhanced toxicity attributed to AβpE peptides.
Insights
Pyroglutamate-modified amyloid-beta (AβpE) peptides form pores in cell membranes, contributing to Alzheimer's disease (AD) toxicity. These AβpE pores exhibit unique structural and functional properties compared to other Aβ pores, offering insights into AD pathogenesis.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Pyroglutamate-modified amyloid-beta (AβpE) peptides are strongly linked to Alzheimer's disease (AD) cytotoxicity.
- AβpE peptides are the predominant Aβ oligomers in AD brains and accumulate before full-length Aβ plaques.
- The increased hydrophobicity and resistance to degradation of AβpE contribute to their toxicity, but pore formation activity remains unclear.
Purpose of the Study:
- To investigate the pore activity of AβpE peptides in anionic lipid membranes.
- To determine the structural characteristics of AβpE pores using molecular dynamics simulations.
- To compare the functional and structural properties of AβpE pores with other Aβ pores.
Main Methods:
- Planar bilayer electrical recording to assess ionic current through AβpE pores.
- Molecular dynamics simulations to elucidate the structural basis of AβpE pore formation and function.
Main Results:
- AβpE pores spontaneously induce ionic current across anionic membranes.
- AβpE pores show delayed onset but increased ion permeability compared to Aβ1-42 pores.
- The N-termini of AβpE peptides in pores orient towards the lipid core, unlike wild-type Aβ peptides.
Conclusions:
- AβpE peptides form functional pores in lipid membranes with distinct properties from other Aβ peptides.
- Structural differences, particularly N-terminal orientation, likely contribute to the enhanced toxicity of AβpE.
- These findings represent a foundational step in understanding the molecular mechanisms underlying AβpE-associated Alzheimer's disease toxicity.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
08:53Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids
Published on: March 21, 2025
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Alzheimer Disease ll: Pathophysiology
Ligand-Gated Ion Channel Receptor: Gating Mechanism